Medical News

RSS

Natus Medical announces $50M revolving credit facility with Wells Fargo Bank

Natus Medical Incorporated today announced that it has entered into a $50 million revolving credit facility with Wells Fargo Bank, National Association. The credit facility, which matures on April 30, 2012, amends and restates the Company's existing $25 million credit facility that was scheduled to mature on April 30, 2010.

27 Apr 2010

Interim results from Phase I clinical trial of PLX-PAD for treatment of CLI

Pluristem Therapeutics Inc. today announced interim top-line results from its Phase I clinical trials utilizing its placenta-derived cell therapy product, PLX-PAD, for the treatment of critical limb ischemia, the end-stage of peripheral artery disease. The interim data demonstrated that PLX-PAD is safe, well tolerated and effective.

27 Apr 2010

Rib-X Pharmaceuticals to demonstrate three presentations at Antibacterial Drug Development Conference

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that it will be presenting three separate presentations at the Cambridge Healthtech Institute's 4th Annual Antibacterial Drug Development Conference, Resistance is Futile: The Challenge of Antibacterial Drug Development, April 27 - 28, in San Diego, CA.

27 Apr 2010

Penalties and fines for sending non-encrypted e-mails including patient information

A new law that took effect in February calls for substantial new penalties on doctors for something they are doing every day – sending e-mails that include patient information, without encrypting the e-mail.

27 Apr 2010

Teleflex' first-quarter 2010 revenues down 1%

Teleflex Incorporated today announced financial results for the first quarter ended March 28, 2010.

27 Apr 2010

Southwest Bancorp prices underwritten public offering of 4,000,000 common stock shares at $12.50 per share

Southwest Bancorp, Inc., today announced that it has priced its underwritten public offering of 4,000,000 shares of common stock at a price to the public of $12.50 per share for net proceeds of approximately $47.0 million. The offering was increased from the previously announced offering size of approximately $40 million. The offering is expected to close on April 29, 2010.

27 Apr 2010

ViroPharma initiates multi-dose Phase 2 study of Cinryze in patients with HAE

ViroPharma Incorporated today announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze (C1 esterase inhibitor [human)] in 24 adolescents and adult subjects with hereditary angioedema.

27 Apr 2010

Waters first-quarter sales increases 10% to $368 million

Waters Corporation reported first quarter 2010 sales of $368 million, an increase of 10% from sales of $333 million in the first quarter of 2009. In the quarter, foreign currency translation increased sales growth rate by 4% and, on a currency neutral basis, sales increased by 6% in comparison to the prior year's first quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the first quarter of 2010 were $0.79, compared to $0.75 for the first quarter of 2009.

27 Apr 2010

Pluristem Therapeutics to raise $2.7M through private placement of restricted common stock

Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.

27 Apr 2010

Iconix Brand Group signs definitive agreement with UFS, Scripps to acquire Peanuts brand and related assets

Iconix Brand Group, Inc., today announced that it has signed a definitive agreement with United Features Syndicate, Inc. and The E.W. Scripps Company to acquire the Peanuts brand and related assets in partnership with the Schulz family.

27 Apr 2010

Energizer Holdings reports 6% increase in second-quarter 2010 net sales

Energizer Holdings, Inc., today announced results of its second quarter ended March 31, 2010. Net earnings for the quarter were $88.5 million, or $1.25 per diluted share, versus net earnings of $77.0 million, or $1.30 per diluted share in the second fiscal quarter of 2009.

27 Apr 2010

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

27 Apr 2010

IntegraMed America's Vein Clinics business grows 20% in first-quarter 2010

IntegraMed America, Inc., the leader in developing and managing specialty healthcare facilities in the fertility and vein care markets, today announced strong results for the first quarter ended March 31, 2010.

27 Apr 2010

Study: Cigarette smoking, fructose consumption can worsen NAFLD

Recent studies suggest that modifiable risk factors such as cigarette smoking and fructose consumption can worsen nonalcoholic fatty liver disease. With NAFLD, fat accumulates in the liver of overweight individuals despite drinking little alcohol, causing in some cases liver scarring that can lead to liver failure.

27 Apr 2010

Amedisys' first-quarter 2010 net service revenues up 20.8%

Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.

27 Apr 2010

Compugen reports revenues of $125,000 for first-quarter 2010

Compugen Ltd. today reported financial results for the first quarter ending March 31, 2010.

27 Apr 2010

First Edition: April 27, 2010

Today's headlines focus on the details of health reform that continue to emerge -- including states' reactions to high risk pools and questions about the sweeping expansion of Medicaid.

27 Apr 2010

Pharmacological suppression of nonsense mutations effective in treating genetic defects

Genetic mutation can disrupt the way human cells make proteins, which in turn leads to inherited disease. David Bedwell, a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are closer than ever to producing drugs that fix this disrupted-protein pathway and drastically improving treatment of genetic disease.

27 Apr 2010

MMC announces acquisition of BGR.com

Mail.com Media Corporation, the digital media company that owns and operates the Mail.com portal and email service as well as a growing portfolio of lifestyle brands including, Deadline.com, HollywoodLife.com, Movieline.com and OnCars.com, announced today its acquisition of BGR.com, one of the top mobile/gadget sites in the world.

27 Apr 2010

Universite de Montreal demographer offers prediction of boomer future

Baby boomers are retiring healthy, financially secure and with a desire to travel. According to Universit- de Montr-al demographer Jacques L-gar-, baby boomers will remain among the most self-reliant generations to reach their golden years.

27 Apr 2010